US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

ADIL Adial Pharmaceuticals Inc

1.2102

-0.0398 (-3.18%)

07 Jun 2024 - Cerrado

Retrasado por 15 minutos

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Adial Pharmaceuticals (NASDAQ:ADIL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Adial Pharmaceuticals.

Adial Pharmaceuticals (NASDAQ:ADIL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Adial Pharmaceuticals.

Noticias sobre Adial Pharmaceuticals Inc ADIL

Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Miércoles 5 de Junio 2024 (3 días hace) • GlobeNewswire Inc.

Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th
Miércoles 29 de Mayo 2024 (1 semana hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Miércoles 15 de Mayo 2024 (3 semanas hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martes 14 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Lunes 22 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Miércoles 10 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Martes 2 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Viernes 1 de Marzo 2024 (3 meses hace) • GlobeNewswire Inc.

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Miércoles 28 de Febrero 2024 (3 meses hace) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Miércoles 14 de Febrero 2024 (4 meses hace) • Edgar (US Regulatory)

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Martes 13 de Febrero 2024 (4 meses hace) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Jueves 25 de Enero 2024 (4 meses hace) • Edgar (US Regulatory)

Más de Adial Pharmaceuticals Inc Artículos de Noticias

Euro vs US Dollar

JP Morgan Chase

Financial Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones